ACROBiosystems Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 926

Employees

  • Stock Symbol
  • 301080

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $12.54
  • (As of Friday Closing)

ACROBiosystems General Information

Description

Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 4th Floor, Building 5
  • Number 8 Hongda North Road, Beijing Economic and Technological Development Zone
  • Beijing
  • China
+86 010
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • 4th Floor, Building 5
  • Number 8 Hongda North Road, Beijing Economic and Technological Development Zone
  • Beijing
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ACROBiosystems Stock Performance

As of 13-Nov-2026, ACROBiosystems’s stock price is $12.54. Its current market cap is $2.1B with 168M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$12.54 $14.20 $5.30 - $21.04 $2.1B 168M 16.1M $0.17

ACROBiosystems Financials Summary

As of 30-Sep-2026, ACROBiosystems has a trailing 12-month revenue of $149M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 3,381,838 1,031,047 484,110 723,581
Revenue 148,821 116,546 89,893 76,843
EBITDA 24,092 26,431 16,696 21,084
Net Income 28,251 23,023 17,258 21,710
Total Assets 470,995 430,150 399,256 396,905
Total Debt 16,186 12,349 19,274 9,115
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ACROBiosystems Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ACROBiosystems‘s full profile, request access.

Request a free trial

ACROBiosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biol
Discovery Tools (Healthcare)
Beijing, China
926 As of 2025

South San Francisco, CA
 

Oklahoma City, OK
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ACROBiosystems Competitors (7)

One of ACROBiosystems’s 7 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Cytovance Biologics Formerly PE-Backed Oklahoma City, OK
Adcytherix Venture Capital-Backed Marseille, France
Oxford Biotherapeutics Private Equity-Backed Oxford, United Kingdom
Mersana Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 5 of 7 competitors. Get the full list »

ACROBiosystems Patents

ACROBiosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021239014-A1 Anti-sars coronavirus-2 spike protein antibodies Inactive 26-May-2020
WO-2021213520-A1 Anti-sars coronavirus-2 spike protein antibodies Inactive 24-Apr-2020
EP-3976660-A1 Anti-b7-h3 antibodies Inactive 28-May-2019
US-20220235134-A1 Anti-b7-h3 antibodies Inactive 28-May-2019
WO-2020238926-A1 Anti-b7-h3 antibodies Inactive 28-May-2019 C07K16/2827
To view ACROBiosystems’s complete patent history, request access »

ACROBiosystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ACROBiosystems Investments (1)

ACROBiosystems’s most recent deal was a Early Stage VC with DialBio. The deal was made on 19-Sep-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DialBio 19-Sep-2022 Early Stage VC Laboratory Services (Healthcare)
To view ACROBiosystems’s complete investments history, request access »

ACROBiosystems ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view ACROBiosystems’s complete esg history, request access »

ACROBiosystems FAQs

  • When was ACROBiosystems founded?

    ACROBiosystems was founded in 2010.

  • Where is ACROBiosystems headquartered?

    ACROBiosystems is headquartered in Beijing, China.

  • What is the size of ACROBiosystems?

    ACROBiosystems has 926 total employees.

  • What industry is ACROBiosystems in?

    ACROBiosystems’s primary industry is Discovery Tools (Healthcare).

  • Is ACROBiosystems a private or public company?

    ACROBiosystems is a Public company.

  • What is ACROBiosystems’s stock symbol?

    The ticker symbol for ACROBiosystems is 301080.

  • What is the current stock price of ACROBiosystems?

    As of 13-Nov-2026 the stock price of ACROBiosystems is $12.54.

  • What is the current market cap of ACROBiosystems?

    The current market capitalization of ACROBiosystems is $2.1B.

  • What is ACROBiosystems’s current revenue?

    The trailing twelve month revenue for ACROBiosystems is $149M.

  • Who are ACROBiosystems’s competitors?

    CytomX Therapeutics, Cytovance Biologics, Adcytherix, Oxford Biotherapeutics, and Mersana Therapeutics are some of the 7 competitors of ACROBiosystems.

  • What is ACROBiosystems’s annual earnings per share (EPS)?

    ACROBiosystems’s EPS for 12 months was $0.17.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process